Bio-techne
TECHTECH · Stock Price
Historical price data
Overview
Bio-Techne's mission is to provide the critical tools and technologies that enable scientific discovery and clinical validation across the life sciences continuum. The company has achieved a leadership position in protein sciences and spatial biology through a disciplined strategy of organic innovation and strategic acquisitions, building a portfolio of trusted brands like R&D Systems, Novus Biologicals, and ProteinSimple. Its strategy focuses on leveraging its core reagent expertise to drive growth in high-value adjacencies, particularly in spatial biology, multi-omics, and clinical diagnostics, serving a stable and diverse global customer base.
Technology Platform
An integrated ecosystem of technologies spanning core protein/antibody reagents, automated protein analysis instruments, and a leading spatial biology platform for in-situ hybridization and sequencing-based spatial transcriptomics, enabling multi-omics research and clinical diagnostics.
FDA Approved Drugs
7Opportunities
Risk Factors
Competitive Landscape
Bio-Techne faces competition from large, diversified players like Thermo Fisher in reagents, and specialized rivals like 10x Genomics, Bruker (NanoString), and Vizgen in the high-growth spatial biology arena. Its competitive moat is built on brand reputation for quality, an integrated portfolio that creates workflow stickiness, and deep scientific expertise.
Company Timeline
Founded in Minneapolis, United States
FDA Approval: AVZIVI
FDA Approval: METHOCARBAMOL
FDA Approval: IBTROZI